FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 90117

Price move▲ Bullish

Johnson & Johnson +2.2%

1 SOURCE CONFIRMED · FIRST SEEN 2026-10-21 01:40 UTC

KINDPrice move
DIRECTION▲ Bullish
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

J&J strength adds to broad healthcare leadership, consistent with defensive rotation into large-cap pharma.

Large-cap pharma firming
CATALYST TO WATCH

Litigation or pipeline news

MAIN RISK

Legal overhang persists

FULL DISPATCH

Johnson & Johnson (JNJ) moved +2.2% in the latest period (1d). Close: 259.36, prior: 253.79.

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

SUBJECTJohnson & Johnson · JNJ
AFFECTEDEli Lilly · LLY
AFFECTEDHealthcare Sector ETF · XLV

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01yfinancefinance.yahoo.com · PRIMARY2026-10-21 01:40 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares XLV, LLY
Eli Lilly +3.5%2026-10-21 01:40 UTC
→CORRELATIONshares JNJ, XLV
UnitedHealth +3.0%2026-10-21 01:40 UTC
→CORRELATIONshares XLV, LLY
Healthcare Sector ETF +2.4%2026-10-21 01:40 UTC
→CORRELATIONshares LLY
iShares Biotech ETF +3.2%2026-10-21 01:40 UTC
←CORRELATIONshares LLY
New Phase 3 trial: A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Eli Lilly and Company2026-10-19 12:00 UTC
←CORRELATIONshares LLY
New Phase 3 trial: A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes — Eli Lilly and Company2026-10-19 12:00 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.